A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Idursulfase
Phenoxypropazine
The risk or severity of adverse effects can be increased when DPDPE is combined with Phenoxypropazine.
Idursulfase
Pheniprazine
The risk or severity of adverse effects can be increased when DPDPE is combined with Pheniprazine.
Idursulfase
Octamoxin
The risk or severity of adverse effects can be increased when DPDPE is combined with Octamoxin.
Idursulfase
Mebanazine
The risk or severity of adverse effects can be increased when DPDPE is combined with Mebanazine.
Idursulfase
Benmoxin
The risk or severity of adverse effects can be increased when DPDPE is combined with Benmoxin.
Idursulfase
Toloxatone
The risk or severity of adverse effects can be increased when DPDPE is combined with Toloxatone.
Idursulfase
Pirlindole
The risk or severity of adverse effects can be increased when DPDPE is combined with Pirlindole.
Idursulfase
Hydracarbazine
The risk or severity of adverse effects can be increased when DPDPE is combined with Hydracarbazine.
Idursulfase
7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline
The risk or severity of adverse effects can be increased when DPDPE is combined with 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline.
Idursulfase
Nialamide
The risk or severity of adverse effects can be increased when DPDPE is combined with Nialamide.
Idursulfase
Iproniazid
The risk or severity of adverse effects can be increased when DPDPE is combined with Iproniazid.
Idursulfase
Clorgiline
The risk or severity of adverse effects can be increased when DPDPE is combined with Clorgiline.
Idursulfase
Pargyline
The risk or severity of adverse effects can be increased when DPDPE is combined with Pargyline.
Idursulfase
Rasagiline
The risk or severity of adverse effects can be increased when DPDPE is combined with Rasagiline.
Idursulfase
Tofisopam
The risk or severity of adverse effects can be increased when Tofisopam is combined with DPDPE.
Idursulfase
Lemborexant
The risk or severity of adverse effects can be increased when DPDPE is combined with Lemborexant.
Idursulfase
JNJ-26489112
The risk or severity of adverse effects can be increased when DPDPE is combined with JNJ-26489112.
Idursulfase
Solriamfetol
The risk or severity of adverse effects can be increased when DPDPE is combined with Solriamfetol.
Idursulfase
Pyrazolam
The risk or severity of adverse effects can be increased when DPDPE is combined with Pyrazolam.
Idursulfase
Eslicarbazepine
The risk or severity of adverse effects can be increased when DPDPE is combined with Eslicarbazepine.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3